• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Meihua International Medical Technologies Co. Ltd.

    11/14/24 6:08:55 PM ET
    $MHUA
    Medical/Dental Instruments
    Health Care
    Get the next $MHUA alert in real time by email
    SC 13G 1 d865645dsc13g.htm SC 13G SC 13G

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

     

    SCHEDULE 13G

    (Rule 13d-102)

    (Amendment No.)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

    RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2(b)

     

     

    MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO., LTD.

    (Name of Issuer)

    Ordinary Shares, $0.0005 par value

    (Title of Class of Securities)

    G5966G108

    (CUSIP Number)

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

     

     


    CUSIP No. G5966G108   

    13G

      

     

     1   

     NAME OF REPORTING PERSONS

     I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

     Anson Funds Management LP

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Texas

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     2,267,301

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     2,267,301

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     2,267,301

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     9.5% **

    12  

     TYPE OF REPORTING PERSON*

     

     IA, PN

     

    *

    SEE INSTRUCTIONS BEFORE FILLING OUT

    **

    SEE ITEM 4(b).

     

    2


    CUSIP No. G5966G108   

    13G

      

     

     1   

     NAME OF REPORTING PERSONS

     I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

     Anson Management GP LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Texas

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     2,267,301

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     2,267,301

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     2,267,301

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     9.5% **

    12  

     TYPE OF REPORTING PERSON*

     

     HC, OO

     

    *

    SEE INSTRUCTIONS BEFORE FILLING OUT

    **

    SEE ITEM 4(b).

     

    3


    CUSIP No. G5966G108   

    13G

      

     

     1   

     NAME OF REPORTING PERSONS

     I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

     Tony Moore

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States Citizen

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     2,267,301

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     2,267,301

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     2,267,301

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     9.5% **

    12  

     TYPE OF REPORTING PERSON*

     

     HC, IN

     

    *

    SEE INSTRUCTIONS BEFORE FILLING OUT

    **

    SEE ITEM 4(b).

     

    4


    CUSIP No. G5966G108   

    13G

      

     

     1   

     NAME OF REPORTING PERSONS

     I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

     Anson Advisors Inc.

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Ontario, Canada

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     2,267,301

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     2,267,301

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     2,267,301

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     9.5% **

    12  

     TYPE OF REPORTING PERSON*

     

     FI, CO

     

    *

    SEE INSTRUCTIONS BEFORE FILLING OUT

    **

    SEE ITEM 4(b).

     

    5


    CUSIP No. G5966G108   

    13G

      

     

     1   

     NAME OF REPORTING PERSONS

     I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

     Amin Nathoo

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Canadian Citizen

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     2,267,301

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     2,267,301

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     2,267,301

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     9.5% **

    12  

     TYPE OF REPORTING PERSON*

     

     HC, IN

     

    *

    SEE INSTRUCTIONS BEFORE FILLING OUT

    **

    SEE ITEM 4(b).

     

    6


    CUSIP No. G5966G108   

    13G

      

     

     1   

     NAME OF REPORTING PERSONS

     I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

     Moez Kassam

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Canadian Citizen

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     2,267,301

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     2,267,301

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     2,267,301

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     9.5% **

    12  

     TYPE OF REPORTING PERSON*

     

     HC, IN

     

    *

    SEE INSTRUCTIONS BEFORE FILLING OUT

    **

    SEE ITEM 4(b).

     

    7


    SCHEDULE 13G

    This Schedule 13G (the “Schedule 13G”) is being filed on behalf of Anson Funds Management LP (d/b/a Anson Funds), a Texas limited partnership, Anson Management GP LLC, a Texas limited liability company, Mr. Tony Moore, the principal of Anson Funds Management LP and Anson Management GP LLC, Anson Advisors Inc., an Ontario, Canada corporation, Mr. Amin Nathoo, a director of Anson Advisors Inc., and Mr. Moez Kassam, a director of Anson Advisors Inc., relating to Ordinary Shares, $0.0005 par value (the “Ordinary Shares”), of Meihua International Medical Technologies CO., LTD., a Cayman Islands corporation (the “Issuer”).

    This Schedule 13G relates to the Ordinary Shares of the Issuer purchased by a private fund to which Anson Funds Management LP and Anson Advisors Inc. serve as co-investment advisors (the “Fund”). Anson Funds Management LP and Anson Advisors Inc. serve as co-investment advisors to the Fund and may direct the vote and disposition of the 2,267,301 shares of Ordinary Shares held by the Fund. As the general partner of Anson Funds Management LP, Anson Management GP LLC may direct the vote and disposition of the 2,267,301 shares of Ordinary Shares held by the Fund. As the principal of Anson Fund Management LP and Anson Management GP LLC, Mr. Moore may direct the vote and disposition of the 2,267,301 shares of Ordinary Shares held by the Fund. As directors of Anson Advisors Inc., Mr. Nathoo and Mr. Kassam may each direct the vote and disposition of the 2,267,301 shares of Ordinary Shares held by the Fund.

     

    Item 1(a)

    Name of Issuer.

    Meihua International Medical Technologies Co., Ltd.

     

    Item 1(b)

    Address of Issuer’s Principal Executive Offices.

    88 Tonga Road, Touqiao Town

    Guangling District, Yangzhou, 225000

    People’s Republic of China

     

    Item 2(a)

    Name of Person Filing.

    Anson Funds Management LP, Anson Management GP LLC, Mr. Tony Moore, Anson Advisors Inc., Mr. Amin Nathoo and Mr. Moez Kassam

     

    Item 2(b)

    Address of Principal Business Office, or, if none, Residence.

    For Anson Funds Management LP, Anson Management GP LLC and Mr. Moore:

    16000 Dallas Parkway, Suite 800

    Dallas, Texas 75248

    For Anson Advisors Inc., Mr. Nathoo and Mr. Kassam:

    181 Bay Street, Suite 4200

    Toronto, ON

    M5J 2T3

     

    8


    Item 2(c)

    Citizenship or Place of Organization.

    Anson Funds Management LP is a limited partnership organized under the laws of the State of Texas. Anson Management GP LLC is a limited liability company organized under the laws of the State of Texas. Mr. Moore is a United States citizen. Anson Advisors Inc. is a corporation organized under the laws of Ontario, Canada. Mr. Nathoo and Mr. Kassam are each Canadian citizens.

     

    Item 2(d)

    Title of Class of Securities.

    Ordinary Shares, $0.0005 par value

     

    Item 2(e)

    CUSIP Number.

    G5966G108

     

    Item 3

    Reporting Person.

    If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:

     

         (a)    ☐    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
      (b)    ☐    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
      (c)    ☐    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
      (d)    ☐    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
      (e)    ☒    An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).
      (f)    ☐    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
      (g)    ☒    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
      (h)    ☐    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
      (i)    ☐    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
      (j)    ☒    A non-U.S. institution that is the functional equivalent of any of the institutions listed in § 240.13d-1 (b)(1)(ii)(A) through (I), so long as the non-U.S. institution is subject to a regulatory scheme that is substantially comparable to the regulatory scheme applicable to the equivalent U.S. institution.
      (k)    ☐    Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     

    9


    Item 4

    Ownership.

     

      (a)

    Anson Funds Management LP, Anson Management GP LLC, Mr. Moore, Anson Advisors Inc., Mr. Nathoo and Mr. Kassam are the beneficial owners of 2,267,301 shares of Ordinary Shares held by the Fund.

     

      (b)

    Anson Funds Management LP, Anson Management GP LLC, Mr. Moore, Anson Advisors Inc., Mr. Nathoo and Mr. Kassam are the beneficial owners of 9.5% of the outstanding shares of Ordinary Shares. This percentage is determined by dividing 2,267,301 by 23,940,000 shares of Ordinary Shares issued and outstanding, as reported in the Issuer’s Quarterly Report on Form 20-F filed with the Securities and Exchange Commission (the “SEC”) on April 24, 2024.

     

      (c)

    Anson Funds Management LP and Anson Advisors Inc., as the co-investment advisors to the Fund, may direct the vote and disposition of the 2,267,301 shares of Ordinary Shares held by the Fund. Anson Management GP LLC, as the general partner of Anson Funds Management LP, may direct the vote and disposition of the 2,267,301 shares of Ordinary Shares held by the Fund. As the principal of Anson Funds Management LP and Anson Management GP LLC, Mr. Moore may direct the vote and disposition of the 2,267,301 shares of Ordinary Shares held by the Fund. Mr. Nathoo and Mr. Kassam, each as a director of Anson Advisors Inc., may direct the vote and disposition of the 2,267,301 shares of Ordinary Shares held by the Fund.

     

    Item 5

    Ownership of Five Percent or Less of a Class.

    Inapplicable.

     

    Item 6

    Ownership of More Than Five Percent on Behalf of Another Person.

    See description regarding the Fund in the introduction, which is incorporated by reference herein.

     

    Item 7

    Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company.

    See description of control persons of Anson Funds Management LP and Anson Advisors Inc. in the introduction, which is incorporated by reference herein.

     

    Item 8

    Identification and Classification of Members of the Group.

    Inapplicable.

     

    Item 9

    Notice of Dissolution of Group.

    Inapplicable.

     

    10


    Item 10

    Certification.

    By signing below each of the Reporting Persons certifies that, to the best of such person’s knowledge and belief, the securities referred to above were acquired and held in the ordinary course of business and were not acquired and were not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    For Anson Advisors Inc.:

    By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to portfolio managers and exempt market dealers is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution. I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

     

    Exhibits

    Exhibit 99.1

    Joint Filing Agreement dated November 14, 2024, by and among Anson Funds Management LP, Anson Management GP LLC, Mr. Moore, Anson Advisors Inc., Mr. Nathoo and Mr. Kassam.

     

    11


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: November 14, 2024

     

    ANSON FUNDS MANAGEMENT LP
    By: Anson Management GP LLC, its general partner
    By:   /s/ Tony Moore
      Tony Moore
      Manager
    ANSON MANAGEMENT GP LLC
    By:   /s/ Tony Moore
      Tony Moore
      Manager
    /s/ Tony Moore
    Tony Moore
    ANSON ADVISORS INC.
    By:   /s/ Amin Nathoo
      Amin Nathoo
      Director
    By:   /s/ Moez Kassam
      Moez Kassam
      Director
    /s/ Amin Nathoo
    Amin Nathoo
    /s/ Moez Kassam
    Moez Kassam

     

    12

    Get the next $MHUA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MHUA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MHUA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results

      YANGZHOU, China, April 25, 2025 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced its financial results for the fiscal year ended December 31, 2024. All amounts below are in U.S. dollars. Fiscal Year 2024 Financial Metrics: Revenues remained stable and decreased slightly to $96.91 million for the year ended December 31, 2024, from approximately $97.10 million for the year ended December 31, 2023. The decrease was mainly due to the Company's disposal of Hainan Guoxie Technology Group Co. Ltd (

      4/25/25 6:05:00 AM ET
      $MHUA
      Medical/Dental Instruments
      Health Care
    • Meihua International Medical Technologies Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement

      YANGZHOU, China, Oct. 7, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that on October 3, 2024, it received a notification letter (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement"). As previously reported, the Company was notified on April 2, 2024, t

      10/7/24 6:00:00 AM ET
      $MHUA
      Medical/Dental Instruments
      Health Care
    • Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results

      YANGZHOU, China, Sept. 20, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today reported its unaudited financial results for the six months ended June 30, 2024. All amounts below are in U.S. dollars. First Half 2024 Unaudited Financial Metrics: Revenues was approximately $45.3 million for the six months ended June 30, 2024.Gross profit was approximately $15.2 million for the six months ended June 30, 2024.Gross margin was approximately 33.5% in the six months ended June 30, 2024.Income from operation

      9/20/24 5:30:00 PM ET
      $MHUA
      Medical/Dental Instruments
      Health Care

    $MHUA
    Leadership Updates

    Live Leadership Updates

    See more
    • Meihua International Medical Technologies Co., Ltd. Appoints New CEO, CFO and Directors

      YANGZHOU, China, Dec. 5, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced the appointments of Mr. Xin Wang as Chief Executive Officer and director, Mr. Lianzhang Zhao as Chief Financial Officer and Ms. Huijuan Zhao as independent board member, member of the compensation committee and audit committee, and chair of the nominating committee, effective as of December 1st, 2022, to fill the vacancies arising from the voluntary resignations of Mr. Yulin Wang as CEO, interim CFO and director of

      12/5/22 9:33:00 AM ET
      $MHUA
      Medical/Dental Instruments
      Health Care
    • Meihua International Medical Technologies Co., Ltd. Appoints New CEO, CFO and Directors

      YANGZHOU, China, Dec. 5, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced the appointments of Mr. Xin Wang as Chief Executive Officer and director, Mr. Lianzhang Zhao as Chief Financial Officer and Ms. Huijuan Zhao as independent board member, member of compensation committee and audit committee, and chair of nominating committee, effective as of December 1st, 2022, to fill the vacancies arising from the voluntary resignations of Mr. Yulin Wang as CEO, interim CFO and director of the Comp

      12/5/22 8:30:00 AM ET
      $MHUA
      Medical/Dental Instruments
      Health Care

    $MHUA
    Financials

    Live finance-specific insights

    See more
    • Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results

      YANGZHOU, China, April 25, 2025 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced its financial results for the fiscal year ended December 31, 2024. All amounts below are in U.S. dollars. Fiscal Year 2024 Financial Metrics: Revenues remained stable and decreased slightly to $96.91 million for the year ended December 31, 2024, from approximately $97.10 million for the year ended December 31, 2023. The decrease was mainly due to the Company's disposal of Hainan Guoxie Technology Group Co. Ltd (

      4/25/25 6:05:00 AM ET
      $MHUA
      Medical/Dental Instruments
      Health Care

    $MHUA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Meihua International Medical Technologies Co. Ltd.

      SC 13G - Meihua International Medical Technologies Co., Ltd. (0001835615) (Subject)

      11/14/24 6:08:55 PM ET
      $MHUA
      Medical/Dental Instruments
      Health Care

    $MHUA
    SEC Filings

    See more
    • SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.

      6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)

      6/6/25 6:30:02 AM ET
      $MHUA
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.

      6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)

      4/25/25 6:36:47 AM ET
      $MHUA
      Medical/Dental Instruments
      Health Care
    • SEC Form 20-F filed by Meihua International Medical Technologies Co. Ltd.

      20-F - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)

      4/25/25 6:32:49 AM ET
      $MHUA
      Medical/Dental Instruments
      Health Care